Literature DB >> 16571825

Recovery of a recombinant salmonid alphavirus fully attenuated and protective for rainbow trout.

Coralie Moriette1, Monique Leberre, Annie Lamoureux, Thanh-Lan Lai, Michel Brémont.   

Abstract

Sleeping disease virus (SDV) is a member of the new Salmonid alphavirus genus within the Togaviridae family. The single-stranded RNA genome of SDV is 11,894 nucleotides long, excluding the 3' poly(A) tail. A full-length cDNA has been generated; the cDNA was fused to a hammerhead ribozyme sequence at the 5' end and inserted into a transcription plasmid (pcDNA3) backbone, yielding pSDV. By transfection of pSDV into fish cells, recombinant SDV (rSDV) was successfully recovered. Demonstration of the recovery of rSDV was provided by immunofluorescence assay on rSDV-infected cells and by the presence of a genetic tag, a BlpI restriction enzyme site, introduced into the rSDV RNA genome. SDV infectious cDNA was used for two kinds of experiments (i) to evaluate the impact of various targeted mutations in nsP2 on viral replication and (ii) to study the virulence of rSDV in trout. For the latter aspect, when juvenile trout were infected by immersion in a water bath with the wild-type virus-like rSDV, no deaths or signs of disease appeared in fish, although they were readily infected. In contrast, cumulative mortality reached 80% in fish infected with the wild-type SDV (wtSDV). When rSDV-infected fish were challenged with wtSDV 3 and 5 months postinfection, a long-lasting protection was demonstrated. Interestingly, a variant rSDV (rSDV14) adapted to grow at a higher temperature, 14 degrees C instead of 10 degrees C, was shown to become pathogenic for trout. Comparison of the nucleotide sequences of wtSDV, rSDV, and rSDV14 genomes evidenced several amino acid changes, and some changes may be linked to the pathogenicity of SDV in trout.

Entities:  

Mesh:

Year:  2006        PMID: 16571825      PMCID: PMC1440445          DOI: 10.1128/JVI.80.8.4088-4098.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant.

Authors:  N L Davis; L V Willis; J F Smith; R E Johnston
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

2.  In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release.

Authors:  P Liljeström; S Lusa; D Huylebroeck; H Garoff
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 4.  Alphavirus-based expression vectors: strategies and applications.

Authors:  I Frolov; T A Hoffman; B M Prágai; S A Dryga; H V Huang; S Schlesinger; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants.

Authors:  C M Rice; R Levis; J H Strauss; H V Huang
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Salmon pancreas disease virus, an alphavirus infecting farmed Atlantic salmon, Salmo salar L.

Authors:  J H Weston; M D Welsh; M F McLoughlin; D Todd
Journal:  Virology       Date:  1999-04-10       Impact factor: 3.616

7.  An RT-PCR-based method for the diagnosis of the sleeping disease virus in experimentally and naturally infected salmonids.

Authors:  S Villoing; J Castric; J Jeffroy; A Le Ven; R Thiery; M Bremont
Journal:  Dis Aquat Organ       Date:  2000-02-24       Impact factor: 1.802

8.  Packaging signals in alphaviruses.

Authors:  E Frolova; I Frolov; S Schlesinger
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Comparison of two aquatic alphaviruses, salmon pancreas disease virus and sleeping disease virus, by using genome sequence analysis, monoclonal reactivity, and cross-infection.

Authors:  Jonathan Weston; Stéphane Villoing; Michel Brémont; Jeanette Castric; Martin Pfeffer; Victoria Jewhurst; Marian McLoughlin; OddMagne Rødseth; Karen Elina Christie; Joseph Koumans; Daniel Todd
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates.

Authors:  Randal J Schoepp; Jonathan F Smith; Michael D Parker
Journal:  Virology       Date:  2002-10-25       Impact factor: 3.616

View more
  17 in total

1.  A fully attenuated recombinant Salmonid alphavirus becomes pathogenic through a single amino acid change in the E2 glycoprotein.

Authors:  Emilie Mérour; Annie Lamoureux; Julie Bernard; Stéphane Biacchesi; Michel Brémont
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

2.  Development of infectious cDNA clones of Salmonid alphavirus subtype 3.

Authors:  Marius Karlsen; Stephane Villoing; Karl F Ottem; Espen Rimstad; Are Nylund
Journal:  BMC Res Notes       Date:  2010-09-21

3.  Characterization of untranslated regions of the salmonid alphavirus 3 (SAV3) genome and construction of a SAV3 based replicon.

Authors:  Marius Karlsen; Stephane Villoing; Espen Rimstad; Are Nylund
Journal:  Virol J       Date:  2009-10-27       Impact factor: 4.099

Review 4.  The reverse genetics applied to fish RNA viruses.

Authors:  Stéphane Biacchesi
Journal:  Vet Res       Date:  2011-01-24       Impact factor: 3.683

5.  Enhanced transfection of cell lines from Atlantic salmon through nucoleofection and antibiotic selection.

Authors:  Berit L Schiøtz; Esther G Rosado; Espen S Baekkevold; Morten Lukacs; Siri Mjaaland; Hilde Sindre; Unni Grimholt; Tor Gjøen
Journal:  BMC Res Notes       Date:  2011-05-06

6.  Low temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formation.

Authors:  Stefan W Metz; Femke Feenstra; Stephane Villoing; Marielle C van Hulten; Jan W van Lent; Joseph Koumans; Just M Vlak; Gorben P Pijlman
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 7.  Viruses of fish: an overview of significant pathogens.

Authors:  Mark Crane; Alex Hyatt
Journal:  Viruses       Date:  2011-10-25       Impact factor: 5.048

8.  The C-Terminal Domain of Salmonid Alphavirus Nonstructural Protein 2 (nsP2) Is Essential and Sufficient To Block RIG-I Pathway Induction and Interferon-Mediated Antiviral Response.

Authors:  Raphaël Jami; Emilie Mérour; Julie Bernard; Annie Lamoureux; Jean K Millet; Stéphane Biacchesi
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

9.  Vaccine Adjuvants in Fish Vaccines Make a Difference: Comparing Three Adjuvants (Montanide ISA763A Oil, CpG/Poly I:C Combo and VHSV Glycoprotein) Alone or in Combination Formulated with an Inactivated Whole Salmonid Alphavirus Antigen.

Authors:  Hanna L Thim; Stéphane Villoing; Marian McLoughlin; Karen Elina Christie; Søren Grove; Petter Frost; Jorunn B Jørgensen
Journal:  Vaccines (Basel)       Date:  2014-03-25

10.  A 6K-deletion variant of salmonid alphavirus is non-viable but can be rescued through RNA recombination.

Authors:  Tz-Chun Guo; Daniel X Johansson; Øyvind Haugland; Peter Liljeström; Øystein Evensen
Journal:  PLoS One       Date:  2014-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.